Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06965608

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers

Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and the Caribbean Code Against Cancer within four different primary healthcare units in Aparecida de Goiânia.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cancer Latin America and the Caribbean Code Against Cancer (LAC Code) Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

HMAP - Hospital Municipal de Aparecida de Goiânia

Aparecida de Goiânia, Goiás, Brazil

Location contact

Mayler O. N. de Santos, MD

CONTACT

[email protected]

+55 62 3878-5100

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (≥18 years old)
  • Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
  • Healthcare professionals with at least three months of employment at a participating UBS
  • Ability to provide informed consent

Exclusion criteria

  • Prior diagnosis of any cancer or currently undergoing cancer treatment

Treatment and study plan

WhatsApp-Based Cancer Prevention Messaging

Behavioral

Participants in this group will receive a structured series of WhatsApp messages containing evidence-based cancer prevention recommendations from the Latin America and Caribbean Code Against Cancer (LAC Code). Messages will be delivered over four weeks, 3 times a week, covering key topics such as smoking cessation, healthy diet, physical activity, and regular screening. Engagement metrics will be tracked to assess feasibility and adherence.

Online Cancer Prevention Workshop for Healthcare Professionals

Behavioral

Healthcare professionals assigned to this group will participate in an online workshop designed to improve their knowledge of the LAC Code and communication strategies for cancer prevention counseling. The workshop includes recorded lectures, interactive modules, and knowledge assessments. Completion rates and participant satisfaction will be measured.

Combined WhatsApp Messaging and Online Workshop

Behavioral

Participants in this group will receive both interventions: WhatsApp messages with cancer prevention recommendations and access to the online workshop. The intervention aims to assess whether a combined approach enhances adherence and impact. Engagement with both interventions will be monitored.

Primary outcomes

  1. Feasibility of the WhatsApp-Based Intervention

    Time frame: Up to 2 weeks after WhatsApp intervention completion

    Number of participants who report having read at least one WhatsApp message.

  2. Acceptability of the WhatsApp-Based Intervention

    Time frame: Up to 2 weeks after WhatsApp intervention completion

    Mean acceptability score from participant survey (Likert scale 1-5) evaluating message usefulness and clarity.

  3. Appropriateness of the WhatsApp-Based Intervention

    Time frame: Up to 2 weeks after WhatsApp intervention completion

    Proportion of participants who indicate willingness to receive similar messages in the future (Yes/No).

Other outcomes

  1. Receipt of Cancer Prevention Counseling Among the General Population (KAS Questionnaire)

    Time frame: Baseline and final assessment (up to 2 weeks after intervention)

    Proportion of general population participants reporting receipt of at least one type of cancer prevention counseling (e.g., smoking cessation, diet, physical activity) as assessed by the KAS questionnaire

  2. Intention to Provide Cancer Prevention Counseling Among Healthcare Professionals (KAP Questionnaire)

    Time frame: Baseline, post-workshop (up to 2 weeks), and final assessment (up to 2 weeks after intervention)

    Proportion of healthcare professionals reporting intention to integrate cancer prevention counseling into clinical practice, assessed via the KAP questionnaire.

Study contacts

Contact information is provided by the study sponsor or research team.

Diogo G Bugano, MD

CONTACT

[email protected]

+551121511233

Sponsors and collaborators

Lead sponsor

Hospital Israelita Albert Einstein

Other

Collaborators

  • International Agency for Research on Cancer

Registry information

Official study title

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers in Aparecida de Goiania (Brazil) - FLACC-Brazil

Acronym: FLACC-Brazil

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
May 11, 2025
Registry last updated
May 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.